Newly identified tree shrew cytochrome P450 2B6 (CYP2B6) and pig CYP2B6b are functional drug-metabolising enzymes

References

• Barnes HJ, Arlotto MP, Waterman MR. 1991. Expression and enzymatic activity of recombinant cytochrome P450 17α-hydroxylase in Escherichia coli. Proc Natl Acad Sci U S A. 88(13):5597–5601.
   PubMed Web of Science ®Google Scholar
• Cao J, Yang EB, Su JJ, Li Y, Chow P. 2003. The tree shrews: adjuncts and alternatives to primates as models for biomedical research. J Med Primatol. 32(3):123–130.
   PubMed Web of Science ®Google Scholar
• Domanski TL, Halpert JR. 2001. Analysis of mammalian cytochrome P450 structure and function by site-directed mutagenesis. Curr Drug Metab. 2(2):117–137.
   PubMed Web of Science ®Google Scholar
• Domanski TL, He YQ, Scott EE, Wang Q, Halpert JR. 2001. The role of cytochrome 2B1 substrate recognition site residues 115, 294, 297, 298, and 362 in the oxidation of steroids and 7-alkoxycoumarins. Arch Biochem Biophys. 394(1):21–28.
   PubMed Web of Science ®Google Scholar
• Fan Y, Huang ZY, Cao CC, Chen CS, Chen YX, Fan DD, He J, Hou HL, Hu L, Hu XT, et al. 2013. Genome of the Chinese tree shrew. Nat Commun. 4:1426.
   PubMed Web of Science ®Google Scholar
• Gervot L, Rochat B, Gautier JC, Bohnenstengel F, Kroemer H, de Berardinis V, Martin H, Beaune P, de Waziers I. 1999. Human CYP2B6: expression, inducibility and catalytic activities. Pharmacogenetics. 9(3):295–306.
   PubMedGoogle Scholar
• Gotoh O. 1992. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J Biol Chem. 267(1):83–90.
   PubMed Web of Science ®Google Scholar
• Heikkinen AT, Friedlein A, Matondo M, Hatley OJ, Petsalo A, Juvonen R, Galetin A, Rostami-Hodjegan A, Aebersold R, Lamerz J, et al. 2015. Quantitative ADME proteomics – CYP and UGT enzymes in the beagle dog liver and intestine. Pharm Res. 32(1):74–90.
   PubMed Web of Science ®Google Scholar
• Hu S, Wang H, Knisely AA, Reddy S, Kovacevic D, Liu Z, Hoffman SM. 2008. Evolution of the CYP2ABFGST gene cluster in rat, and a fine-scale comparison among rodent and primate species. Genetica. 133(2):215–226.
   PubMed Web of Science ®Google Scholar
• Iwata H, Fujita K, Kushida H, Suzuki A, Konno Y, Nakamura K, Fujino A, Kamataki T. 1998. High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli. Biochem Pharmacol. 55(8):1315–1325.
   PubMed Web of Science ®Google Scholar
• Kojima M, Degawa M. 2016. Sex differences in constitutive mRNA levels of CYP2B22, CYP2C33, CYP2C49, CYP3A22, CYP3A29 and CYP3A46 in the pig liver: comparison between Meishan and Landrace pigs. Drug Metab Pharmacokinet. 31(3):185–192.
   PubMed Web of Science ®Google Scholar
• Kojima M, Morozumi T. 2004. Cloning of six full-length cDNAs encoding pig cytochrome P450 enzymes and gene expression of these enzymes in the liver and kidney. Journal of Health Science. 50(5):518–529.
   Web of Science ®Google Scholar
• Lang T, Klein K, Fischer J, Nüssler AK, Neuhaus P, Hofmann U, Eichelbaum M, Schwab M, Zanger UM. 2001. Extensive genetic polymorphism in the human CYP2B6 gene with impact on expression and function in human liver. Pharmacogenetics. 11(5):399–415.
   PubMedGoogle Scholar
• Lin HL, Zhang H, Kenaan C, Hollenberg PF. 2016. Roles of residues F206 and V367 in human CYP2B6: effects of mutations on androgen hydroxylation, mechanism-based inactivation, and reversible inhibition. Drug Metab Dispos. 44(11):1771–1779.
   PubMed Web of Science ®Google Scholar
• Martinez MN, Antonovic L, Court M, Dacasto M, Fink-Gremmels J, Kukanich B, Locuson C, Mealey K, Myers MJ, Trepanier L. 2013. Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics. Drug Metab Rev. 45(2):218–230.
   PubMed Web of Science ®Google Scholar
• Martinez SE, Andresen MC, Zhu Z, Papageorgiou I, Court MH. 2020. Pharmacogenomics of poor drug metabolism in greyhounds: cytochrome P450 (CYP) 2B11 genetic variation, breed distribution, and functional characterization. Sci Rep. 10(1):69.
   PubMed Web of Science ®Google Scholar
• Martinez SE, Shi J, Zhu HJ, Perez Jimenez TE, Zhu Z, Court MH. 2019. Absolute quantitation of drug-metabolizing cytochrome P450 enzymes and accessory proteins in dog liver microsomes using label-free standard-free analysis reveals interbreed variability. Drug Metab Dispos. 47(11):1314–1324.
   PubMed Web of Science ®Google Scholar
• Mayumi K, Hanioka N, Masuda K, Koeda A, Naito S, Miyata A, Narimatsu S. 2013. Characterization of marmoset CYP2B6: cDNA cloning, protein expression and enzymatic functions. Biochem Pharmacol. 85(8):1182–1194.
   PubMed Web of Science ®Google Scholar
• Nannelli A, Chirulli V, Longo V, Gervasi PG. 2008. Expression and induction by rifampicin of CAR- and PXR-regulated CYP2B and CYP3A in liver, kidney and airways of pig. Toxicology. 252(1-3):105–112.
   PubMed Web of Science ®Google Scholar
• Nelson DR, Zeldin DC, Hoffman SM, Maltais LJ, Wain HM, Nebert DW. 2004. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics. 14(1):1–18.
   PubMedGoogle Scholar
• Oshio T, Uehara S, Uno Y, Inoue T, Sasaki E, Yamazaki H. 2019. Marmoset cytochrome P450 2B6, a propofol hydroxylase expressed in liver. Xenobiotica. 49(3):265–269.
   PubMed Web of Science ®Google Scholar
• Puccinelli E, Gervasi PG, Longo V. 2011. Xenobiotic metabolizing cytochrome P450 in pig, a promising animal model. Curr Drug Metab. 12(6):507–525.
   PubMed Web of Science ®Google Scholar
• Rasmussen MK, Scavenius C, Gerbal-Chaloin S, Enghild J. 2019. Sex dictates the constitutive expression of hepatic cytochrome P450 isoforms in Gottingen minipigs. Toxicol Lett. 314:181–186.
   PubMed Web of Science ®Google Scholar
• Shimada T, Tsumura F, Yamazaki H. 1999. Prediction of human liver microsomal oxidations of 7-ethoxycoumarin and chlorzoxazone with kinetic parameters of recombinant cytochrome P-450 enzymes. Drug Metab Dispos. 27(11):1274–1280.
   PubMed Web of Science ®Google Scholar
• Tsukiyama-Kohara K, Kohara M. 2014. Tupaia belangeri as an experimental animal model for viral infection. Exp Anim. 63(4):367–374.
   PubMed Web of Science ®Google Scholar
• Uno Y, Fujino H, Kito G, Kamataki T, Nagata R. 2006. CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone. Mol Pharmacol. 70(2):477–486.
   PubMed Web of Science ®Google Scholar
• Uno Y, Iwasaki K, Yamazaki H, Nelson DR. 2011. Macaque cytochromes P450: nomenclature, transcript, gene, genomic structure, and function. Drug Metab Rev. 43(3):346–361.
   PubMed Web of Science ®Google Scholar
• Uno Y, Shimizu M, Ogawa Y, Makiguchi M, Kawaguchi H, Yamato O, Ishizuka M, Yamazaki H. 2022. Molecular and functional characterization of flavin-containing monooxygenases in pigs, dogs, and cats. Biochem Pharmacol. 202:115125.
   PubMed Web of Science ®Google Scholar
• Wang H, Negishi M. 2003. Transcriptional regulation of cytochrome p450 2B genes by nuclear receptors. Curr Drug Metab. 4(6):515–525.
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Ueng YF, Shimada T, Guengerich FP. 1995. Roles of divalent metal ions in oxidations catalyzed by recombinant cytochrome P450 3A4 and replacement of NADPH–cytochrome P450 reductase with other flavoproteins, ferredoxin, and oxygen surrogates. Biochemistry. 34(26):8380–8389.
   PubMed Web of Science ®Google Scholar
• Yamazaki M, Shimizu M, Uno Y, Yamazaki H. 2014. Drug oxygenation activities mediated by liver microsomal flavin-containing monooxygenases 1 and 3 in humans, monkeys, rats, and minipigs. Biochem Pharmacol. 90(2):159–165.
   PubMed Web of Science ®Google Scholar
• Yun CH, Ahn T, Guengerich FP. 1998. Conformational change and activation of cytochrome P450 2B1 induced by salt and phospholipid. Arch Biochem Biophys. 356(2):229–238.
   PubMed Web of Science ®Google Scholar
• Zanger UM, Klein K. 2013. Pharmacogenetics of cytochrome P450 2B6 (CYP2B6): advances on polymorphisms, mechanisms, and clinical relevance. Front Genet. 4:24.
   PubMedGoogle Scholar